Single-Use Bioprocessing Market Demand, Industry Trends, Analysis Report 2022-2027

Global Single-Use Bioprocessing Market Outlook:

The latest report by IMARC Group, titled “Single-Use Bioprocessing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast  2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on the global Single-Use Bioprocessing Market Outlook. The report also includes competitor and regional analysis, and contemporary advancements in the global market.  The global single-use bioprocessing market reached a value of US$ 12.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 31.5 Billion by 2027, exhibiting a CAGR of 18.4% during 2022-2027.

Single-use bioprocessing refers to systems used to produce and manufacture various pharmaceutical products and solutions. Single-use bioreactors, filtration assemblies, media bags, containers, disposable connectors, mixers, tubes and samplers are some of the commonly used single-use bioprocessing products. They are designed for one-time use and are composed primarily of plastic components that have been sealed and sterilized using gamma irradiation. Single-use bioprocessing is used in the production of vaccines, monoclonal antibodies, plant cell cultivation and specific cell therapies. They assist in increasing productivity, timesaving, reducing the risk of cross-contamination, minimizing the dependence on energy and water, easy disposal, and cost-effectiveness. As a result, single-use bioprocessing is widely adopted by biopharmaceutical manufacturers and life science research organizations.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviors of the consumers globally–our estimates about the latest market trends and forecast values after considering the impact of this pandemic. These observations will be integrated into the report.

Request for a free sample of this report:

Global Single-Use Bioprocessing Market Trends:

The significant growth in the pharmaceutical industry across the globe is creating a positive outlook for the market. Single-use bioprocessing is widely used for achieving an enhanced production of vaccines, monoclonal antibodies, and personalized medicines and in media preparation and shipping of biologics. In line with this, the steadily rising geriatric population and the increasing prevalence of chronic conditions and diseases are favoring the market growth. Apart from this, various technological advancements, such as the utilization of machine learning (ML), automation and big data solutions in bioprocessing to improve accuracy and predict errors during medical procedures, are providing an impetus to the market growth. Additionally, manufacturers are widely adopting single-use bioprocessing as it utilizes high-grade polymer materials and plastic composites and offers various advantages, such as easy disposal, enhanced integral strength and cost-effectiveness, which, in turn, is augmenting the market growth. Other factors, including the widespread product adoption during the development phase of drugs, extensive research and development (R&D) activities, and the rising healthcare expenditure, are anticipated to drive the market toward growth.

Global Single-Use Bioprocessing Market 2022-2027 Analysis and Segmentation:

Competitive Landscape With Key Players :

  • Applikon Biotechnology BV
  • Boehringer Ingelheim International GmbH
  • Cesco Bioengineering Co. Ltd., Corning Inc.
  • Danaher Corporation, Entegris, Inc.
  • Eppendorf AG, Finesse Solutions, Inc.
  • General Electric (GE) Company
  • Infors AG
  • Merck KGaA,
  • Rentschler Biopharma SE
  • Sartorius AG
  • Thermo Fisher Scientific Inc. and 3M Company

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market. Some of these players include Applikon Biotechnology, Boehringer Ingelheim, Cesco Bioengineering Company, Corning Inc., Danaher Corporation, Entegris, Eppendorf AG, Finesse Solutions Inc., GE Healthcare, Infors, Merck Millipore, Rentschler Biotechnologie, Sartorius Stedim Biotech, Thermo Fisher Scientific, 3M Company, etc.

Key Market Segmentation:

Product Type:

  • Media Bags and Containers
  • Filtration Assemblies
  • Single-Use Bioreactors
  • Disposable Mixers
  • Others

On the basis of the product type, the market has been classified into media bags and containers, filtration assemblies, single-use bioreactors, disposable mixers, and others.


  • Filtration
  • Storage
  • Cell Culture
  • Mixing
  • Purification

Based on the application, the market has been divided into filtration, storage, cell culture, mixing, and purification


  • Upstream
  • Fermentation
  • Downstream

On the basis of the end-use, the market has been classified into upstream, fermentation, and downstream.


  • Biopharmaceutical Manufacturers
  • Life Science R&D
  • Others

Based on the end-user the market has been categorized into biopharmaceutical manufacturers, life science R&D, and others.


  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Based on the region, the market has been categorized into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia and Others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and Others) Latin America (Brazil, Mexico and Others), Middle East and Africa.

Key Highlights of the Report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization

Read More: